Recombinant multi-species PKLR protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PKLR protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a pyruvate kinase that catalyzes the transphosphorylation of phohsphoenolpyruvate into pyruvate and ATP, which is the rate-limiting step of glycolysis. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CNSHA2,PK1,PKL,PKLR,PKRL,Pk-1,Pk1,Pklg,Pklr,Pyruvate kinase 1,Pyruvate kinase PKLR,Pyruvate kinase isozymes L/R,R-PK,R-type/L-type pyruvate kinase,RPK,Red cell/liver pyruvate kinase
Go
to PKLR products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP9614-Ag-1/ GM-Tg-hg-IP9614-Ag-2 | Human PKLR protein | Human |
| GM-Tg-rg-IP9614-Ag-1/ GM-Tg-rg-IP9614-Ag-2 | Rat PKLR protein | Rat |
| GM-Tg-mg-IP9614-Ag-1/ GM-Tg-mg-IP9614-Ag-2 | Mouse PKLR protein | Mouse |
| GM-Tg-cynog-IP9614-Ag-1/ GM-Tg-cynog-IP9614-Ag-2 | Cynomolgus/Rhesus macaque PKLR protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP9614-Ag-1/ GM-Tg-felg-IP9614-Ag-2 | Feline PKLR protein | Feline |
| GM-Tg-cang-IP9614-Ag-1/ GM-Tg-cang-IP9614-Ag-2 | Canine PKLR protein | Canine |
| GM-Tg-bovg-IP9614-Ag-1/ GM-Tg-bovg-IP9614-Ag-2 | Bovine PKLR protein | Bovine |
| GM-Tg-equg-IP9614-Ag-1/ GM-Tg-equg-IP9614-Ag-2 | Equine PKLR protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP9614-Ag-1/ GM-Tg-hg-IP9614-Ag-2;
GM-Tg-rg-IP9614-Ag-1/ GM-Tg-rg-IP9614-Ag-2;
GM-Tg-mg-IP9614-Ag-1/ GM-Tg-mg-IP9614-Ag-2; GM-Tg-cynog-IP9614-Ag-1/ GM-Tg-cynog-IP9614-Ag-2; GM-Tg-felg-IP9614-Ag-1/ GM-Tg-felg-IP9614-Ag-2; GM-Tg-cang-IP9614-Ag-1/ GM-Tg-cang-IP9614-Ag-2; GM-Tg-bovg-IP9614-Ag-1/ GM-Tg-bovg-IP9614-Ag-2; GM-Tg-equg-IP9614-Ag-1/ GM-Tg-equg-IP9614-Ag-2 |
| Products Name | PKLR protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PKLR |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PKLR protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.